Department of Chemical Engineering, Imperial College London

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies

Retrieved on: 
Tuesday, October 10, 2023

Mana.bio's integrated experimental and machine learning platform enables the discovery of smarter, faster, more precise delivery formulations to unlock the field of nucleic acid-based and genetic medicines.

Key Points: 
  • Mana.bio's integrated experimental and machine learning platform enables the discovery of smarter, faster, more precise delivery formulations to unlock the field of nucleic acid-based and genetic medicines.
  • We are encouraged by our platform's early in vivo success and for its potential to deliver breakthrough therapies for a broad range of diseases."
  • RNA-based therapies and genetic medicines offer immense potential to transform approaches to vaccines, gene editing, gene therapy and more.
  • The limitations on delivery methods have severely restricted the full therapeutic promise of RNA, CRISPR and gene therapies.

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

Retrieved on: 
Monday, September 18, 2023

MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.

Key Points: 
  • MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.
  • MAVERICK offers all the advantages of Raman spectroscopy without the cost and complexities associated with conventional spectroscopic methods.
  • MAVERICK’s purpose-built de novo models automatically process Raman spectra from a wide variety of culture media types and cell lines, delivering actionable process parameters or direct process control actions.
  • MAVERICK is part of 908 Devices’ suite of devices to help expedite bioprocessing development, including MAVEN – introduced earlier this year -- and REBEL .

Asia Flow Chemistry Conference 2023: Revolutionizing Chemistry - Exploring Cutting-edge Developments (Tokyo, Japan - October 5-6, 2023)

Retrieved on: 
Monday, September 18, 2023

The Flow Chemistry Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.This annual event brings together researchers from around the world and across Japan and features academic presentations, industry presentations, an exhibit hall with companies from around the world plus extensive networking opportunities.This conference features 4-co-located tracks enabling extensive scientific exchanges and networking across disciplines -- your registration provides access to all conference tracks, all content and all networking events.In addition to an exhibit hall, the conference also includes poster sessions and encourages attendees to submit posters as a means to showcase their research and engage with the participants. 

Key Points: 
  • DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The "Flow Chemistry Asia 2023" conference has been added to ResearchAndMarkets.com's offering.
  • The Flow Chemistry Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.
  • This conference features 4-co-located tracks enabling extensive scientific exchanges and networking across disciplines -- your registration provides access to all conference tracks, all content and all networking events.
  • 2nd our AI software which further minimizes pulsation thru AI learning of the pulsation patterns and adjusting the motor speed.

Biosenta announces further advances in research and development of Tri-Filler™

Retrieved on: 
Tuesday, August 8, 2023

TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation.

Key Points: 
  • TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation.
  • Preliminary testing points to the Tri-Filler™ being effective in inhibiting the growth of both gram-positive and gram-negative bacteria and fungi.
  • Biosenta has identified a number of industry partners with whom Biosenta and the University of Calgary team are in various stages of talks for further research and commercialization.
  • Biosenta Inc., a ground-breaking pioneer in the field of antimicrobial solutions, is on a mission to revolutionize the material world.

Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

Retrieved on: 
Tuesday, May 23, 2023

EDMONTON, Alberta, May 23, 2023 (GLOBE NEWSWIRE) --  Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced encouraging results from it’s completed pre-clinical CHRP study conducted with McMaster University evaluating PGX-processed yeast beta glucan (PGX-YBG) as a potential therapeutic option for individuals suffering from interstitial lung diseases (ILD).

Key Points: 
  • ILD damages the tissues between the small air sacs in the lungs (alveoli) and the blood vessels around them.
  • ILD represent a significant unmet medical need and is currently putting a major strain on healthcare systems around the globe.
  • Prior to the pandemic, Ceapro and accomplished researchers from McMaster University teamed up to develop a novel drug formulation for the potential treatment of IPF.
  • We are very encouraged by the results from this study showing that PGX-YBG has the ability of reprogramming macrophages to prevent fibrogenesis in mice.

CITGO CEO Carlos Jordá Among Six Alumni Honored by Michigan Tech

Retrieved on: 
Tuesday, May 2, 2023

HOUSTON, May 2, 2023 /PRNewswire/ -- Carlos Jordá, President and CEO of CITGO Petroleum Corporation, was recently honored by the Department of Chemical Engineering at Michigan Technological University.

Key Points: 
  • HOUSTON, May 2, 2023 /PRNewswire/ -- Carlos Jordá, President and CEO of CITGO Petroleum Corporation, was recently honored by the Department of Chemical Engineering at Michigan Technological University.
  • Jordá, a 1971 graduate of Michigan Tech, was one of six alumni named to the department's Distinguished Academy.
  • "I was honored to receive this recognition from my alma mater, Michigan Tech," said Jordá.
  • "I hope my career inspires current and future chemical engineering students at Michigan Tech," said Jordá.

Auburn University appoints Mario Eden as its new dean of the Samuel Ginn College of Engineering

Retrieved on: 
Friday, April 14, 2023

Mario Eden succeeds Steve Taylor, who was named as interim dean in April 2022.

Key Points: 
  • Mario Eden succeeds Steve Taylor, who was named as interim dean in April 2022.
  • "The quality of applicants and applications we received from across the country is testimony to the stature of the Samuel Ginn College of Engineering," Nathan said.
  • Eden earned master's and doctoral degrees in chemical engineering from the Technical University of Denmark in 1999 and 2003, respectively.
  • "Serving Auburn University's Samuel Ginn College of Engineering and the Department of Chemical Engineering has been one of the greatest blessings of my life," Eden said.

Engineering the Extraordinary: AIChE's 2022 Gala will Celebrate Companies and Their Leaders

Retrieved on: 
Tuesday, July 19, 2022

Organized around the theme Engineering the Extraordinary, the gala will spotlight the contributions of Chevron, a multinational energy company.

Key Points: 
  • Organized around the theme Engineering the Extraordinary, the gala will spotlight the contributions of Chevron, a multinational energy company.
  • Chevron is being honored not only for its engineering commitment to a low-carbon energy future but also for its dedication to promoting diversity in the workforce.
  • Chevron will be represented at the gala byMichael K. Wirth, Chevrons Chairman of the Board and Chief Executive Officer.
  • These leaders exemplify the engineering profession and the many ways that engineering continues to improve the quality of life for all.

Christopher B. Roberts begins first day as Auburn University's 21st president

Retrieved on: 
Monday, May 16, 2022

AUBURN, Ala., May 16, 2022 /PRNewswire/ -- Christopher B. Roberts officially became Auburn University's 21st president on Monday, beginning a new era of continued excellence for the university he's called home for nearly three decades.

Key Points: 
  • AUBURN, Ala., May 16, 2022 /PRNewswire/ -- Christopher B. Roberts officially became Auburn University's 21st president on Monday, beginning a new era of continued excellence for the university he's called home for nearly three decades.
  • "In my 28 years on the Plains, I've come to value and cherish everything that makes the Auburn experience truly remarkable and distinctive," Roberts said.
  • "I've developed a deep appreciation for our unique culture and how to achieve ambitious goals here at Auburn.
  • Roberts and his wife, Tracy, have two children, both having graduated from Auburn High School and attended Auburn University.

PyroGenesis Announces $273,000 Plasma Torch Contract with European Research Centre to Reduce GHGs

Retrieved on: 
Monday, February 7, 2022

Ethylene (C2H4), an olefinic chemical, is the largest volume organic chemical produced globally and a basic building block for the chemistry industry.

Key Points: 
  • Ethylene (C2H4), an olefinic chemical, is the largest volume organic chemical produced globally and a basic building block for the chemistry industry.
  • This contract, although small, once again underscores our plasma torch expertise and the significant benefits of PyroGenesis offerings which specifically reduce GHGs, and reinforces our ability to offer unique, versatile and meaningful solutions that expand the addressable market opportunities for the Company, said Mr. P. Peter Pascali, CEO and President of PyroGenesis.
  • We could not be prouder of the fact that our plasma torches are consistently being selected by cutting-edge entities around the world.
  • Part I: Process Development and Technical Performance, Yaser Khojasteh Salkuyeh and Thomas A. Adams II, Department of Chemical Engineering, McMaster University